Toronto, Canada

Christopher E Pearson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Osaka University, The Hospital for Sick Children. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher E Pearson. Retrieved from https://idiyas.com/inventor/christopher-e-pearson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher E Pearson: Innovator in Genetic Research

Introduction

Christopher E Pearson is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of genetic research, particularly in the treatment of diseases associated with repeat DNA instability. His innovative methods have the potential to change the landscape of genetic therapies.

Latest Patents

Christopher E Pearson holds a patent for "Methods of treating diseases associated with repeat instability." This patent describes methods that can inhibit the further expansion of repeat DNA and, in some instances, reduce the size of the repeat DNA, effectively addressing the challenges posed by repeat DNA instability.

Career Highlights

Throughout his career, Pearson has worked with prestigious institutions, including The Hospital for Sick Children and Osaka University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Masayuki Nakamori and Kazuhiko Nakatani. Their collaborative efforts have further advanced the understanding and treatment of genetic diseases.

Conclusion

Christopher E Pearson's innovative work in genetic research and his patent on treating diseases associated with repeat DNA instability highlight his significant contributions to the field. His efforts continue to pave the way for advancements in genetic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…